U.S., Nov. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07232966) titled 'Perirenal Adipose Tissue Modification Therapy for Resistant Hypertension' on Nov. 14.
Brief Summary: The goal of this clinical trial is to investigate if focused power ultrasound (FPU) targeted perirenal adipose tissue modification therapy would be effective and safe in treating resistant hypertension. The primary outcome of the study is the difference in the reduction of 24h mean systolic blood pressure between treatment and sham procedure groups 6 months after treatment. The secondary outcomes include the reduction of clinic blood pressure 1, 3, and 6 months after treatment, the reduction of 24h mean blood pressure 1, 3, and 6 mon...